Limitations to using point of care blood ketone testing to monitor DKA treatment

Practical Diabetes

Volumn 30, Issue 9, 2013, Pages 380-383

  Armer, Jane ^a   Hunt, Natalie ^a   Kaushal, Kalpana ^a   Myers, Martin ^a  

^a LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; KETONE;

CAPILLARY BLOOD; DIABETIC KETOACIDOSIS; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; PATIENT MONITORING; PERIPHERAL CIRCULATION; POINT OF CARE TESTING; PRACTICE GUIDELINE;

EID: 84898445087     PISSN: None     EISSN: 20472900     Source Type: Journal    
DOI: 10.1002/pdi.1818     Document Type: Letter

References (3)

1. Savage MW, et al. Joint British Societies guideline for the management of diabetic ketoacidosis. Diabet Med 2011;28: 508-15.
2. Janssen MJ, et al. Accuracy of the Precision point of care ketone test examined by liquid chromatography tandem mass spectrometry (LC-MS/MS) in the same fingerstick sample. Clin Chem Lab Med 2010;48: 1781-4.
3. MHRA Point of Care Testing Blood Glucose Meters - Advice for Healthcare Professionals 2011. Available at www.mhra.gov.uk/Publications/Postersand leaflets/CON2015499 [last accessed October 2013].